Introduction
Neuropeptide Y (NPY) is a 36-amino acid peptide co-released with norepinephrine (NE) during sympathetic nerve activation. NPY stimulates different G-protein coupled receptors termed Y 1 , Y 2 , Y 3 , Y 4 and Y 5 [8, 10] . NPY is an important modulator of sympathetic function, as it potentiates adrenergic vasoconstrictor activity by stimulating the Y 1 receptor [3] .
In the heart and blood vessels of a variety of animals, NPY exerts pre-junctional inhibitory effects on NE release from sympathetic nerve endings by activating the Y 2 receptor [12] . In addition, as observed in mice, parasympathetic nerve terminals in the heart possess Y 2 receptors which, when activated, reduce acetylcholine release [11] . We have shown that Y 1 knock-out mice (Y 1 À/À) lose their ability to potentiate NE-induced vasoconstriction, but still have a normal blood pressure, suggesting a minor role of NPY in the maintenance of blood pressure regulation [9] . Recently, the role of NPY in cardiac sympathovagal balance was investigated in mice lacking the Y 1 receptor. A lower heart rate was observed in Y 1 À/À animals, which was compatible with a reduced sympathetic and/or an increased parasympathetic nerve activity [2] . We have recently shown that NPY triggers the release of catecholamines in primary cultures of mice adrenal chromaffin cells, and that this effect is abolished in corresponding cells isolated from adrenal glands of Y 1 À/À animals [1] . Compared to Y 1 +/+ mice, both the adrenal content and the constitutive release of catecholamines were increased in chromaffin cells from Y 1 À/À mice. The high turnover of adrenal catecholamines in Y 1 À/À mice was associated with an enhancement of tyrosine hydroxylase (TH) activity and expression. In resting animals, plasma catecholamine concentrations were higher in Y 1 À/À mice compared to wild-type mice. This is compatible with a role of NPY in controlling the release and the synthesis of catecholamines from the adrenal medulla [1] .
The implication of the Y 1 receptor in the hemodynamic response to an acute sympathetic stimulation has not yet been studied in mice. This urged us to compare the blood pressure and heart rate response to a cold pressor test (CPT) in Y 1 +/+ and Y 1 À/À mice.
2.
Material and methods
Animals
We used 3-month-old male and female mice lacking the NPY Y 1 receptor [9] and their corresponding wild-type homologues (C57BL/6). They were backcrossed for eight generations on a C57BL/6 background (IFFA Credo, L'Arbresle, France) by crossing heterozygous Y 1 À/+ with C57BL/6 wild-type mice. Heterozygous mice were then crossed together in order to produce homozygous mutants (Y 1 À/À) and wild-type control littermates (Y 1 +/+).
Catecholamine determination in mice plasma
The mice were anesthetized with halothane and underwent catheterization of the right carotid artery for blood sampling, heart rate and blood pressure monitoring as described below. They were allowed to recover from anaesthesia for 4 h. Blood was collected through the arterial line (0.2 ml/sample) and centrifuged immediately at 2000 g as previously described [4] . This method of sampling is minimally stressful and appropriate to measure plasma catecholamine in mice [4] . Plasma was separated and frozen at À80 8C until assayed. NE and E in plasma were extracted on alumina and measured by HPLC with electrochemical detection [5] .
Cold pressor test
Cold pressor test was performed by placing mice in custommade Plexiglas tubes partially immersed into ice-cold water for 15 min. In these mice, blood was collected through the arterial line 15 min before the CPT, and again 30 s after the end of the experiment. Simultaneously, blood pressure and heart rate were measured as described below.
Blood pressure and heart rate
The right common carotid artery was exposed through a cervical incision and isolated by blunt dissection. A catheter, formed by a length of PE-10 tubing, was filled with a solution of glucose (5%) and heparin (300 IU/ml) and inserted into the vessel. Xylocaine solution (1%) was used to prevent spasm. Then, a ligature was tied around the artery, and the catheter was tunnelled subcutaneously to exit at the back of the neck. Mice were allowed to recover from the anaesthesia for 4 h and then were placed in Plexiglas tubes to partially restrict their movements. Thirty minutes later, the arterial line was connected to a pressure transducer, and blood pressure (MAP) and heart rate (HR) were recorded starting 2 min before the test (B = baseline) and each min along the 15 min duration of the test. This was done using a computerized dataacquisition system (Hewlett-Packard scanner, model HP3852A). Systolic, diastolic, and mean intra-arterial pressures as well as HR were measured simultaneously. Data represent the average of recordings obtained immediately before the onset of the test (3 min period) minute per minute during the 5 min after starting the test, and at the end of the CPT (t 15 min) [13] . The baroreflex sensitivity was determined based on the ratio of HR under MAP at each time point along the duration of the test.
Statistical analysis
The results were analysed by two-way multivariate analysis of variance for repeated measurements using the STATA software, Version 8. 
Results

Plasma catecholamine concentrations
Baseline plasma NE and E concentrations were increased in Y 1 À/À compared to wild-type mice both in males and females (n = 9), ( p < 0.05) Fig 
3.2.
Mean arterial blood pressure (MAP) and heart rate (HR)
MAP
Basal MAP values were similar in the four groups of resting animals (Y 1 À/À and Y 1 +/+ mice, males or females; Fig. 2A ). CPT induced a rapid and similar increase of MAP in the males and females of both genotypes. One and 2 min after the beginning of the test, an increase in MAP was observed, reaching a maximum at 2 min to decrease at pre-test levels at the end of the CPT (15 min).
HR
At baseline, wild-type males had significantly higher HR values than corresponding females ( p < 0.05), whereas no such a difference was found in Y 1 À/À animals (Fig. 2B) . Males reached occasionally significantly higher HR than females during the CPT. At the end of CPT (15 min), in all study groups, HR was significantly lower than at baseline, regardless of the genotype.
Baroreceptor reflex sensitivity
The analysis of the ratio between the changes in HR and then in MAP at all the recorded time points did not reveal differences between Y 1 À/À and Y 1 +/+ mice ( p = 0.19) (data not shown). The sensitivity of the baroreflex calculated during the maximal decrease (or increase) MAP or HR, was similar in all the study groups ( p = 0.87) (data not shown).
Discussion
This study shows that plasma catecholamine concentrations increase markedly in response to a CPT in Y 1 À/À compared to Y 1 +/+ mice, whereas MAP and HR behave similarly regardless to the genotype. CPT is a potent stimulus of sympathetic nerve activity, which manifests by increased catecholamine levels, transient blood pressure rise, and heart rate acceleration. This may appear surprising since BIBP3226, a Y 1 antagonist has been shown to blunt CPT-induced pressor effects in rats [7, 14] . In our study, the CPT-induced MAP increase was preserved in the Y 1 À/À mice, which could be explained by an increased synthesis and release of catecholamines to compensate for the lack of Y 1 stimulation by NPY. The adrenergic response to CPT is mainly pain-and partially temperature-mediated [7] . However, E and NE released by the adrenal medulla reach target organs via the circulation, whereas NE originating from sympathetic nerve endings produces its effects locally; it is only afterwards that the amine overflows from the synaptic cleft into the circulation [6] . Differences were observed between males and females with regard to plasma NE and E concentrations. This is consistent with our previous observation that adrenal glands from female mice contain smaller amounts of catecholamines than those of males [1] .
The MAP response to CPT was similar in Y 1 +/+ and Y 1 À/À mice, despite the achievement of higher plasma catecholamine concentrations in the latter. This heightened catecholamine discharge observed in Y 1 À/À animals may represent a compensatory mechanism to maintain normal hemodynamics in the absence of the Y 1 receptor.
The effects of the deletion of the Y 1 receptor on HR are complex. The only consistent finding was that Y 1 À/À females had a less pronounced reflex bradycardia at the end of the CPT. In the absence of Y 1 receptors, NPY released by sympathetic nerve terminals and the adrenal medulla can still stimulate presynaptic Y 2 receptors, decreasing thereby the release of NE by sympathetic nerve terminals, as well as the release of acetylcholine by parasympathetic nerve terminals. The fact that Y 1 receptor deficient mice exhibited a less pronounced heart rate decrease at the end of the CPT, compared with Y 1 +/+ animals, suggests a predominant contribution of the parasympathetic system in this response.
In conclusion, Y 1 À/À mice maintain a normal blood pressure response to activation of the sympathetic nerve 
system. This is most likely due to an increased catecholamine discharge in the absence of Y 1 receptors. 
